SASarah Averbach

Sarah Averbach

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sarah Averbach has a total of 164 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    “I don’t have the right to decide by myself, as it is his child too.” Exploring the process of abortion decision-making among women in Nepal

    by Sunita Karki, Alisha Poudel, Sarah Averbach, Diana Greene Foster, Mahesh C. Puri

    Background: In Nepal, the legalization and expansion of safe abortion services have significantly reduced severe abortion-related complications. However, despite the availability of safe abortion care, many individuals face challenges in accessing these services. This study aims to explore the complexities of abortion decision-making among women seeking abortion care in Nepal, focusing on the socio-cultural, economic, and interpersonal dynamics that influence their decisions. Methods: As part of a longitudinal cohort study, we conducted 43 in-depth interviews with women accessing abortion services in 2022. Among these women, 19 received abortion services, while 24 were denied abortions and continued their pregnancies. Using the socio-ecological model (SEM) as the analytical framework, we employed thematic analysis to examine how individual characteristics, interpersonal relationship, community norms and health system factors influenced abortion decision-making. Results: Our findings reveal a complex interplay of factors, including individual health concerns, financial limitations, partner influence, family dynamics, and societal norms, such as gender preference for sons that influence abortion decision-making. Among these, societal norms and partner influence had the most significant impact while making decisions. Conclusion: This study underscores the urgent need for targeted interventions to enhance access to reproductive health information, empower women to advocate for their reproductive rights, guide family engagement, and challenge cultural biases at the individual, interpersonal, and community levels.

  • Open Access

    Postpartum integration of infant vaccines and contraception through gender transformative programming: A cluster randomized trial in India

    by Sarah Averbach, Mohan Ghule, Gennifer Kully, Nicole E. Johns, Madhusudan Battala, Vedavati Patwardhan, Anita Raj, Shahina Begum

    Barriers to using contraception in India include norms that promote gender inequality by restricting mobility of women to reach health clinics. We evaluated whether PIVoT (Postpartum Integration of Vaccines and contraception through gender-Transformative programming) improves contraceptive use while enhancing autonomy in contraceptive decision-making. PIVoT delivers the full spectrum of contraceptive methods available along with gender-transformative counseling, linked with community-based infant vaccination. We conducted a cluster randomized trial; 20 Anganwadi Community centers were randomized to PIVoT or the standard-of-care. We included women 18 years and older, within 12 weeks postpartum, presenting for infant vaccination at community centers in rural Maharashtra, India. We measured contraceptive use (primary outcome) and reproductive autonomy after six months. From September 2023 to June 2024, we enrolled 293 women: 143 at intervention and 150 at control sites. Follow-up at six months was 95%. Any contraceptive use was more common for the control group at baseline (n = 57, 39.9% vs n = 93, 62.0%, p < 0.001) and for the intervention group at follow-up (n = 67, 48.9% vs n = 53, 37.3%, p = 0.051). There was a time-by-treatment effect for any contraceptive use (adjusted ratio of odds ratios 3.98, 95% CI 1.95-8.12). IUD use was slightly higher at six months in the intervention group (2.9% vs 0%, p = 0.04). Use of female-controlled methods (permanent contraception, pills, IUDs, injectables) was higher at six months among the intervention group (13.1% vs 6.3%, p = 0.04). Reproductive decision-making autonomy was higher among intervention participants at follow-up (2.02 vs 1.93, p = 0.02). The PIVoT intervention may increase contraceptive use postpartum, particularly female-controlled methods, while improving reproductive autonomy.

  • Open Access

    Medication Abortion Provision by Advance Practice Clinicians and Abortion Completeness

    by Sarah Averbach, Michelle Luneau, Sheila K. Mody, Gennifer Kully, Nicole E. Johns, Vedavati Patwardhan, Antoinette M. Marengo

    This cohort study compares the estimated effectiveness of medication abortions administered by physicians vs other advance practice clinicians.

  • Open Access

    Expulsion rates 12 months after early versus interval postpartum intrauterine device placement: a randomized trial

    by Sarah Averbach, Florin Vaida, Erica Hinz, Gennifer Kully, Arnab K. Dey, Monica A. Lutgendorf, Sadia Haider, Lisa G. Hofler

  • Open Access

    Pain With Early Postpartum Intrauterine Device Placement

    by Holly H. Berkley, Monica A. Lutgendorf, Gennifer Msc Kully, Sorana Msc Raiciulescu, Sharon K. Stortz, Erica Hinz, Lisa G. Md Hofler, Sarah Md Averbach

    OBJECTIVE: To compare pain between early and interval postpartum intrauterine device (IUD) placement. METHODS: This is a planned secondary outcome analysis of a randomized trial among 404 participants randomized to early (14–28 days) or interval (42–56 days) postpartum IUD placement. Participants reported pain using a 100-mm visual analog scale at three times during IUD placement (bimanual examination, speculum placement, and IUD placement). We estimated that 112 participants would be required to achieve 80% power with an α of 5% to detect a 15-mm difference in pain with IUD placement. We used linear mixed models adjusting for demographic differences to compare mean pain scores between groups and per-protocol sensitivity analyses to account for crossover. RESULTS: We enrolled 404 participants between March 2018 and July 2021; 325 received IUDs and were included in the analysis of pain with placement. Mean pain scores reported were not different between the early and interval groups: bimanual (9.2 mm vs 6.95 mm, mean difference 2.25 mm [95% CI, −2.68 to7.17], P=.37, respectively); speculum (16.95 mm vs 15.86 mm, mean difference 1.09 mm [95% CI, −3.38 to 6.0], P=.66); and IUD placement (18.43 mm vs 20.9 mm, mean difference −2.47 mm [95% CI, −7.39 to 2.44], P=.32). In the per-protocol analysis, pain scores were not meaningfully different from those in the primary intention-to-treat analysis. CONCLUSION: Pain reported is not different among people who are postpartum having early and interval IUD placement. Understanding the experience of pain with early and interval placement may help clinicians support patients in making informed choices about the timing of IUD placement. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, NCT03462758.

  • Open Access

    Psychometric evaluation of the desire to avoid pregnancy scale in India

    by Sarah Averbach, Nicole E. Johns, Shweta Tomar, Marielle E. Meurice, Namratha Rao, Mohan Ghule, Anita Raj


  • Open Access

    Assessing the impact of CHARM2, a family planning program on gender attitudes, intimate partner violence, reproductive coercion, and marital quality in India

    by Sangeeta Chatterji, Nicole E. Johns, Mohan Ghule, Shahina Begum, Sarah Averbach, Madhusudana Battala, Anita Raj

    Using a two-armed cluster randomised controlled trial, CHARM2 (Counselling Husbands to Achieve Reproductive health and Marital equity), a 5-session gender equity and family planning intervention for couples in rural India, showed an impact on family planning outcomes in primary trial analyses. This study examines its effects on gender-equitable attitudes, intimate partner violence, reproductive coercion, and marital quality. We used multilevel mixed-effects models to assess the intervention impact on each outcome. Both male (aIRR at 9 months: 0.64, C.I.: 0.45,0.90; aIRR at 18 months: 0.25, C.I.: 0.18,0.39) and female (aIRR at 9 months: 0.57, C.I.: 0.46,0.71; aIRR at 18 months: 0.38, C.I.: 0.23,0.61) intervention participants were less likely than corresponding control participants to endorse attitudes accepting physical IPV at 9- and 18-month follow-ups. Men in the intervention, compared to those in the control condition, reported more gender-equitable attitudes at 9- and 18 months (ß at 9 months: 0.13, C.I.: 0.06,0.20; ß at 18 months: 0.26, C.I.: 0.19,0.34) and higher marital quality at the 18-month follow-up (ß: 0.03, C.I.: 0.01,0.05). However, we found no effects on women’s experiences of IPV, reproductive coercion, or marital quality. CHARM2 shows promise in improving men’s and women’s attitudes towards gender equality and male perceptions of marital quality. Still, IPV and reproductive coercion reductions may require more intensive programming than that provided within this 5-session model focused on family planning.


  • Open Access

    Pharmacist provision of medication abortion: A pilot study

    by Selina Sandoval, Sally Rafie, Gennifer Kully, Sheila Mody, Sarah Averbach


  • Open Access

    The Association Between Self-Managed versus Clinician-Managed Abortion and Self-Reported Abortion Complications: A Cross-Sectional Analysis in India

    by Sophie Goemans, Abhishek Singh, Ajit Kumar Yadav, Lotus McDougal, Anita Raj, Sarah H Averbach

    Purpose: To examine the association between self-managed abortion and the self-reported experience of abortion complications in India, a country with a high incidence of self-managed abortion. Patients and Methods: The study used a cross-sectional multivariable logistic regression analysis of data from the National Family Health Survey (NFHS-4) of 2015– 2016 to compare the odds of self-reported complications experienced during abortion between self-managed and clinician-managed abortions in India. Results: On average, self-managed abortions occurred earlier in gestation than clinician-managed abortions, 7.8 weeks and 11.3 weeks, respectively (p < 0.001). Self-managed abortion was associated with fewer self-reported abortion-related complications than clinician-managed abortions when adjusted for covariates not including gestational age (Adjusted Odds Ratio (aOR) 0.82, 95% confidence interval (CI) 0.69, 0.97). However, once adjusted for gestational age, there was no longer a clinically meaningful or statistically significant difference in the odds of self-reported complications between self-managed and clinician-managed abortions (aOR = 0.98, 95% CI 0.81, 1.18). Conclusion: These findings suggest that people in India are using safe methods to self-manage abortions and support the hypothesis that self-managed abortion can improve access to abortion and reproductive choice without increasing risk.


  • IUD Expulsion Rates After Early Postpartum vs Interval Placement—Reply

    by Sarah Averbach, Florin Vaida, Lisa G. Hofler

    In Reply We agree with Drs Gao and Zhang that understanding the effectiveness of IUDs to prevent pregnancy is important to adequately weigh the risks and benefits of early postpartum IUD placement. Although IUDs are well known to be highly effective,1 our study was not designed to adequately assess the effectiveness of early postpartum IUDs for pregnancy prevention. We did report all pregnancies in the trial2; 2 pregnancies occurred during use of an IUD among the 294 participants who received an IUD and completed 6-month follow-up (1 in the early placement group and 1 in the interval placement group). In addition, the rates of effective contraception were reported as IUD utilization at 6 months and were similar between groups.